TY - JOUR
T1 - Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from coats plus.
AU - Livingston, John H
AU - Mayer, Josephine
AU - Jenkinson, Emma
AU - Kasher, Paul
AU - Stivaros, Stavros
AU - Berger, Andrea
AU - Cordelli, Duccio M
AU - Ferreira, Patrick
AU - Jefferson, Rosalind
AU - Kutschke, Georg
AU - Lundberg, Staffan
AU - Ounap, Katrin
AU - Prabhakar, Prab
AU - Soh, Calvin
AU - Stewart, Helen
AU - Stone, Jon
AU - van der Knaap, Marjo S
AU - van Esch, Hilda
AU - van Mol, Christine
AU - Wakeling, Emma
AU - Whitney, Andrea
AU - Rice, Gillian I
AU - Crow, Yanick J
N1 - G0600485, Medical Research Council, United Kingdom
PY - 2014/6
Y1 - 2014/6
N2 - OBJECTIVE: With the identification of mutations in the conserved telomere maintenance component 1 (CTC1) gene as the cause of Coats plus (CP) disease, it has become evident that leukoencephalopathy with calcifications and cysts (LCC) is a distinct genetic entity. PATIENTS AND METHODS: A total of 15 patients with LCC were identified from our database of patients with intracranial calcification. The clinical and radiological features are described. RESULTS: The median age (range) at presentation was 10 months (range, 2 days-54 years). Of the 15 patients, 9 presented with epileptic seizures, 5 with motor abnormalities, and 1 with developmental delay. Motor abnormalities developed in 14 patients and cognitive problems in 13 patients. Dense calcification occurred in the basal ganglia, thalami, dentate nucleus, brain stem, deep gyri, deep white matter, and in a pericystic distribution. Diffuse leukoencephalopathy was present in all patients, and it was usually symmetrical involving periventricular, deep, and sometimes subcortical, regions. Cysts developed in the basal ganglia, thalamus, deep white matter, cerebellum, or brain stem. In unaffected areas, normal myelination was present. No patient demonstrated cerebral atrophy. CONCLUSION: LCC shares the neuroradiological features of CP. However, LCC is a purely neurological disorder distinguished genetically by the absence of mutations in CTC1. The molecular cause(s) of LCC has (have) not yet been determined.
AB - OBJECTIVE: With the identification of mutations in the conserved telomere maintenance component 1 (CTC1) gene as the cause of Coats plus (CP) disease, it has become evident that leukoencephalopathy with calcifications and cysts (LCC) is a distinct genetic entity. PATIENTS AND METHODS: A total of 15 patients with LCC were identified from our database of patients with intracranial calcification. The clinical and radiological features are described. RESULTS: The median age (range) at presentation was 10 months (range, 2 days-54 years). Of the 15 patients, 9 presented with epileptic seizures, 5 with motor abnormalities, and 1 with developmental delay. Motor abnormalities developed in 14 patients and cognitive problems in 13 patients. Dense calcification occurred in the basal ganglia, thalami, dentate nucleus, brain stem, deep gyri, deep white matter, and in a pericystic distribution. Diffuse leukoencephalopathy was present in all patients, and it was usually symmetrical involving periventricular, deep, and sometimes subcortical, regions. Cysts developed in the basal ganglia, thalamus, deep white matter, cerebellum, or brain stem. In unaffected areas, normal myelination was present. No patient demonstrated cerebral atrophy. CONCLUSION: LCC shares the neuroradiological features of CP. However, LCC is a purely neurological disorder distinguished genetically by the absence of mutations in CTC1. The molecular cause(s) of LCC has (have) not yet been determined.
KW - coats plus
KW - intracranial calcification
KW - leukoencephalopathy
U2 - 10.1055/s-0033-1364180
DO - 10.1055/s-0033-1364180
M3 - Article
C2 - 24407470
SN - 1439-1899
VL - 45
SP - 175
EP - 182
JO - Neuropediatrics
JF - Neuropediatrics
IS - 3
ER -